Skip to content

AERIE PHARMACEUTICALS INC

Delisted

CIK 1337553fmd_1HKSY3FC2MWZ54C2QQENKHRHJ2Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2005 to Sep 30, 2022, 50 periods

Latest annual · FY2021

Millions
Total revenues
194
Gross profit
167
Operating income
(46)
Net income
(75)
Free cash flow
(102)

Latest quarter · Q3 FY2022

Millions
Total revenues
36
Gross profit
29
Operating income
(27)
Net income
(27)
Free cash flow
(12)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2018 to FY2021
+100.2%
Revenue, 5 yearsFY2016 to FY2021
n/m
Net income, 5 yearsFY2016 to FY2021
n/m

AERIE PHARMACEUTICALS INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$194.1 million$83.1 million+133.5%10-K 2022-02-25 · proof
Gross profit$167.3 million$57.8 million+189.4%10-K 2022-02-25 · proof
Operating income-$46.4 million-$155.7 million10-K 2022-02-25 · proof
Net income-$74.8 million-$183.1 million10-K 2022-02-25 · proof
Cash from operating activities-$99.2 million-$64.7 million10-K 2022-02-25 · proof
Free cash flow-$102.4 million-$67.8 million10-K 2022-02-25 · proof
Total assets$431.4 million$402 million+7.3%10-K 2022-02-25 · proof
Total liabilities$448.7 million$378.1 million+18.7%10-K 2022-02-25 · proof
Cash and cash equivalents$37.2 million$151.6 million-75.5%10-K 2022-02-25 · proof
What was AERIE PHARMACEUTICALS INC's revenue in fiscal 2021?
AERIE PHARMACEUTICALS INC reported revenue of $194.1 million for fiscal 2021 (the year ended Dec 31, 2021), against $83.1 million the year before (+133.5%). Source: the 10-K filed with the SEC on Feb 25, 2022. SEC
What was AERIE PHARMACEUTICALS INC's gross profit in fiscal 2021?
AERIE PHARMACEUTICALS INC reported gross profit of $167.3 million for fiscal 2021 (the year ended Dec 31, 2021), against $57.8 million the year before (+189.4%). Source: the 10-K filed with the SEC on Feb 25, 2022. SEC
What was AERIE PHARMACEUTICALS INC's operating income in fiscal 2021?
AERIE PHARMACEUTICALS INC reported operating income of -$46.4 million for fiscal 2021 (the year ended Dec 31, 2021), against -$155.7 million the year before. Source: the 10-K filed with the SEC on Feb 25, 2022. SEC
What was AERIE PHARMACEUTICALS INC's net income in fiscal 2021?
AERIE PHARMACEUTICALS INC reported net income of -$74.8 million for fiscal 2021 (the year ended Dec 31, 2021), against -$183.1 million the year before. Source: the 10-K filed with the SEC on Feb 25, 2022. SEC
What was AERIE PHARMACEUTICALS INC's cash from operating activities in fiscal 2021?
AERIE PHARMACEUTICALS INC reported cash from operating activities of -$99.2 million for fiscal 2021 (the year ended Dec 31, 2021), against -$64.7 million the year before. Source: the 10-K filed with the SEC on Feb 25, 2022. SEC
What was AERIE PHARMACEUTICALS INC's free cash flow in fiscal 2021?
AERIE PHARMACEUTICALS INC reported free cash flow of -$102.4 million for fiscal 2021 (the year ended Dec 31, 2021), against -$67.8 million the year before. Source: the 10-K filed with the SEC on Feb 25, 2022. SEC
What are AERIE PHARMACEUTICALS INC's total assets?
As of Dec 31, 2021, AERIE PHARMACEUTICALS INC reported total assets of $431.4 million, against $402 million a year earlier (+7.3%). Source: the 10-K filed with the SEC on Feb 25, 2022. SEC
What are AERIE PHARMACEUTICALS INC's total liabilities?
As of Dec 31, 2021, AERIE PHARMACEUTICALS INC reported total liabilities of $448.7 million, against $378.1 million a year earlier (+18.7%). Source: the 10-K filed with the SEC on Feb 25, 2022. SEC
What are AERIE PHARMACEUTICALS INC's cash and cash equivalents?
As of Dec 31, 2021, AERIE PHARMACEUTICALS INC reported cash and cash equivalents of $37.2 million, against $151.6 million a year earlier (-75.5%). Source: the 10-K filed with the SEC on Feb 25, 2022. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1337553&period_type=annual&limit=5"

Information only, not investment advice.